Article
Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study.
Archives of internal medicine - 12 May 2003
Tan Zaldy Sy, Seshadri Sudha, Beiser Alexa, Wilson Peter W F, Kiel Douglas P, Tocco Michael, D'Agostino Ralph B, Wolf Philip A
Abstract excerpt
BACKGROUND: Previous studies examining the association of plasma cholesterol levels with the risk for development of Alzheimer disease (AD) have been inconclusive. We examined the impact of baseline and lifetime plasma total cholesterol levels averaged across many years on the risk for AD in a large, population-based cohort. METHODS: Five thousand two hundred nine subjects from the Framingham Study original...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.